Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2019
At a glance
- Drugs Tesamorelin (Primary)
- Indications Peripheral nerve injuries
- Focus Therapeutic Use
- 12 Jul 2018 Status changed from not yet recruiting to recruiting.
- 22 May 2018 Planned initiation date changed from 1 Mar 2018 to 1 Jun 2018.
- 15 Feb 2018 Planned initiation date changed from 1 Jul 2017 to 1 Mar 2018.